Page last updated: 2024-10-15
tremolite
Description
tremolite: see also actinolite; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 131634194 |
MeSH ID | M0047651 |
Synonyms (6)
Synonym |
---|
tremolite |
tremolite asbestos |
asbestos, tremolite |
77536-68-6 |
qn851s6iry , |
abkhazite |
Research Excerpts
Overview
Tremolite is an amphibole which has been implicated in a variety of disease patterns in different parts of the world. It is present in some chrysotile, talc, and vermiculite deposits.
Excerpt | Reference |
---|---|
"Tremolite is a noncommercial form of amphibole mineral that is present in some chrysotile, talc, and vermiculite deposits. " | ( Evaluation of tremolite asbestos exposures associated with the use of commercial products. Adams, RE; Barlow, CA; Finley, BL; Paustenbach, DJ; Phelka, AD; Pierce, JS; Thuett, KA, 2012) |
"Tremolite is an amphibole which has been implicated in a variety of disease patterns in different parts of the world. " | ( Biological effects of tremolite. Berry, G; Brown, RC; Chamberlain, M; Davies, R; Griffiths, DM; Pooley, FD; Wagner, JC, 1982) |
Effects
Tremolite contamination has been proposed as the cause of mesothelioma in workers exposed to commercial chrysotile. Tremolite has been associated with an increased risk of lung cancer in a study of vermiculite miners.
Excerpt | Reference |
---|---|
"Tremolite contamination has been proposed as the cause of mesothelioma in workers exposed to commercial chrysotile. " | ( A case of occupational peritoneal mesothelioma from exposure to tremolite-free chrysotile in Quebec, Canada: A black swan case. Egilman, D; Menéndez, LM, 2011) |
"Tremolite has been associated with an increased risk of lung cancer in a study of vermiculite miners; the slope of the exposure-response relationship was similar to that for crocidolite miners and much higher than that of chrysotile miners." | ( Human evidence: lung cancer mortality risk from chrysotile exposure. Hughes, JM, 1994) |
Treatment
Excerpt | Reference |
---|---|
"Rats treated with tremolite developed very high levels of pulmonary fibrosis as well as 16 carcinomas and two mesotheliomas in a group of 39 animals." | ( Inhalation studies on the effects of tremolite and brucite dust in rats. Addison, J; Bolton, RE; Davis, JM; Donaldson, K; Jones, AD; Miller, BG, 1985) |
Toxicity
Excerpt | Reference |
---|---|
" Despite weathered fibers appearing less toxic than "stored/laboratory" ones, NOA is to be considered far from safe because of fibrous nature and residual surface reactivity." | ( The effect of weathering on ecopersistence, reactivity, and potential toxicity of naturally occurring asbestos and asbestiform minerals. Compagnoni, R; Enrico Favero-Longo, S; Fubini, B; Piervittori, R; Tomatis, M; Turci, F, 2009) |
"Naturally occurring asbestos (NOA) fibers are found in geologic deposits that may be disturbed by mining, earthworks, or natural processes, resulting in adverse health risks to exposed individuals." | ( Long-term toxicity of naturally occurring asbestos in male Fischer 344 rats. Cyphert, JM; Gavett, SH; Kodavanti, UP; McGee, MA; Nyska, A; Schladweiler, MC, 2016) |
Dosage Studied
Excerpt | Reference |
---|---|
" The ambient dosage of asbestos has confirmed the existence of environmental pollution by chrysotile fibres and above all by tremolite." | ( [Environmental mesotheliomas in northeast Corsica]. Billon-Galland, MA; Boutin, C; De Vuyst, P; Dumortier, P; Farisse, P; Hereng, P; Rey, F; Viallat, JR, 1993) |
" Our study reveals the critical nature of EMP morphometric parameters for exposure assessment and dosing approaches used in toxicity studies." | ( Differential responses of murine alveolar macrophages to elongate mineral particles of asbestiform and non-asbestiform varieties: Cytotoxicity, cytokine secretion and transcriptional changes. Guppi, S; Khaliullin, TO; Kisin, ER; Shvedova, AA; Yanamala, N; Zhernovkov, V, 2020) |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (192)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 37 (19.27) | 18.7374 |
1990's | 47 (24.48) | 18.2507 |
2000's | 47 (24.48) | 29.6817 |
2010's | 46 (23.96) | 24.3611 |
2020's | 15 (7.81) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (0.49%) | 5.53% |
Reviews | 14 (6.90%) | 6.00% |
Case Studies | 15 (7.39%) | 4.05% |
Observational | 1 (0.49%) | 0.25% |
Other | 172 (84.73%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |